![Mf 89 [DSM 44676, W5198]](/static/images/no_picture.jpg)
-
平臺(tái)編號(hào)：bio-087823
-
國(guó)際編號(hào)：ATCC 49403
-
拉丁屬名： Mycobacterium houstonense
-
規(guī)格：freeze-dried
-
用途：ATCC原裝進(jìn)口
-
服務(wù)費(fèi)用：
加載中…… - 訂購(gòu)
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫(kù)為準(zhǔn)）
Mf 89 [DSM 44676, W5198]
Mycobacterium houstonense Schinsky et al. 拉丁名
(ATCC? 49403?)統(tǒng)一編號(hào)
Deposited As Mycobacterium fortuitum da Costa Cruz
Strain Designations 別名 Mf 89 [DSM 44676, W5198]
Isolation 分離基物 Tissue, human, Houston Texas, United States, January, 1980
Biosafety Level 生物安全等級(jí) 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format 提供形式 Freeze-dried
Preceptrol? no
Type Strain 模式菌種 yes Ref
Comments 注釋 Biovariant 3
Medium 培養(yǎng)基 ATCC? Medium 44: Brain Heart Infusion Agar/Broth
Growth Conditions 生長(zhǎng)條件
Temperature 培養(yǎng)溫度: 37.0°C
Atmosphere 需氧情況: Aerobic
Name of Depositor 寄存者 RJ Wallace
Isolation 分離基物 Tissue, human, Houston Texas, United States, January, 1980
References 參考文獻(xiàn) Wallace RJ J, et al. Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum. J. Infect. Dis. 163: 598-603, 1991. PubMed: 1995732
Schinsky MF, et al. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates.. Int. J. Syst. Evol. Microbiol. 54: 1653-1667, 2004. PubMed: 15388725
face wound
Schinsky MF, et al. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates.. Int. J. Syst. Evol. Microbiol. 54: 1653-1667, 2004. PubMed: 15388725
Cross References Nucleotide (GenBank) : X65528 M.fortuitum 16S rRNA (ATCC 49403).
Nucleotide (GenBank) : AY012579 Mycobacterium houstonense 16S ribosomal RNA gene, partial sequence.
Nucleotide (GenBank) : U86085 Mycobacterium fortuitum superoxide dismutase (SOD) gene, partial cds.
Nucleotide (GenBank) : S74032 tetK=tetracycline resistant [Mycobacterium fortuitum, ATCC 49403, Genomic Mutant, 308 nt].
ATCC49403
(ATCC? 49403?)統(tǒng)一編號(hào)
Deposited As Mycobacterium fortuitum da Costa Cruz
Strain Designations 別名 Mf 89 [DSM 44676, W5198]
Isolation 分離基物 Tissue, human, Houston Texas, United States, January, 1980
Biosafety Level 生物安全等級(jí) 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format 提供形式 Freeze-dried
Preceptrol? no
Type Strain 模式菌種 yes Ref
Comments 注釋 Biovariant 3
Medium 培養(yǎng)基 ATCC? Medium 44: Brain Heart Infusion Agar/Broth
Growth Conditions 生長(zhǎng)條件
Temperature 培養(yǎng)溫度: 37.0°C
Atmosphere 需氧情況: Aerobic
Name of Depositor 寄存者 RJ Wallace
Isolation 分離基物 Tissue, human, Houston Texas, United States, January, 1980
References 參考文獻(xiàn) Wallace RJ J, et al. Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum. J. Infect. Dis. 163: 598-603, 1991. PubMed: 1995732
Schinsky MF, et al. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates.. Int. J. Syst. Evol. Microbiol. 54: 1653-1667, 2004. PubMed: 15388725
face wound
Schinsky MF, et al. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates.. Int. J. Syst. Evol. Microbiol. 54: 1653-1667, 2004. PubMed: 15388725
Cross References Nucleotide (GenBank) : X65528 M.fortuitum 16S rRNA (ATCC 49403).
Nucleotide (GenBank) : AY012579 Mycobacterium houstonense 16S ribosomal RNA gene, partial sequence.
Nucleotide (GenBank) : U86085 Mycobacterium fortuitum superoxide dismutase (SOD) gene, partial cds.
Nucleotide (GenBank) : S74032 tetK=tetracycline resistant [Mycobacterium fortuitum, ATCC 49403, Genomic Mutant, 308 nt].
ATCC49403
